Amgen Inc. (ETR:AMG)
254.30
-1.15 (-0.45%)
Oct 10, 2025, 5:35 PM CET
Amgen Revenue
Amgen had revenue of $9.18B USD in the quarter ending June 30, 2025, with 9.43% growth. This brings the company's revenue in the last twelve months to $34.92B, up 12.88% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$34.92B
Revenue Growth
+12.88%
P/S Ratio
4.52
Revenue / Employee
$1.25M
Employees
28,000
Market Cap
134.37B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | 23.36B | -385.00M | -1.62% |
Dec 31, 2018 | 23.75B | 898.00M | 3.93% |
Dec 31, 2017 | 22.85B | -142.00M | -0.62% |
Dec 31, 2016 | 22.99B | 1.33B | 6.14% |
Dec 31, 2015 | 21.66B | 1.60B | 7.97% |
Dec 31, 2014 | 20.06B | 1.39B | 7.43% |
Dec 31, 2013 | 18.68B | 1.41B | 8.17% |
Dec 31, 2012 | 17.27B | 1.68B | 10.80% |
Dec 31, 2011 | 15.58B | 529.00M | 3.51% |
Dec 31, 2010 | 15.05B | 411.00M | 2.81% |
Dec 31, 2009 | 14.64B | -361.00M | -2.41% |
Dec 31, 2008 | 15.00B | 232.00M | 1.57% |
Dec 31, 2007 | 14.77B | 503.00M | 3.53% |
Dec 31, 2006 | 14.27B | 1.84B | 14.79% |
Dec 31, 2005 | 12.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Amgen News
- 1 day ago - Hap Sneddon's Top Picks: Amgen, Algonquin Power & iShares Dow Jones US Insurance Index Fund ETF - BNN Bloomberg
- 4 days ago - Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers - CNBC
- 4 days ago - Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% - Nasdaq
- 5 days ago - Amgen (AMGN) Shares Fall Following Discounted Drug Pricing Announcement - GuruFocus
- 5 days ago - Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices - Benzinga
- 5 days ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 5 days ago - Amgen (AMGN) Reduces Price for Cholesterol Drug Repatha - GuruFocus
- 5 days ago - Amgen to offer Repatha at 60% discount to U.S. consumers - Seeking Alpha